MedTrace Logo

Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff

NCT04799808 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2022-08-04

No results posted yet for this study

Summary

To investigate short- (3 and 8 weeks) and long-term (6, 9, 12, and 18 months) immune protection or response at the humoral and cellular levels before and after SARS-CoV-2 infection or vaccination in patients with moderately reduced immune status (dialysis patients) and severely reduced immune status (organ transplant recipients, mostly kidney transplant recipients) and immunocompetent subjects (medical staff) in Saxony, Germany.

Conditions

Sponsors & Collaborators

  • Universitätsklinikum Leipzig

    collaborator OTHER

  • Klinikum St. Georg gGmbH

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • DRK-Blutspendedienst Nord-Ost gemeinnützige GmbH / Dresden

    collaborator UNKNOWN

  • DRK-Blutspendedienst Nord-Ost gemeinnützige GmbH / Institut Plauen

    collaborator UNKNOWN

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Christian Hugo, Prof. · Univercity Hospital Carl Gustav Carus

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2023-07-31
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04799808 on ClinicalTrials.gov